OpenAlex
PricingAboutJobs
Log inGet started
Work

Galectin-3 and its inhibitors: Overview and perspectives

HTML

Year: 2026
Type: review
Source: Pharmacology & Therapeutics
DOI: 10.1016/j.pharmthera.2026.109125
Authors: Shuanglin Liu, Shengjie Wu, Fei He, Kan Ding
Institutions: Chinese Academy of Sciences, Shanghai Institute of Materia Medica, University of Chinese Academy of Sciences, State Key Laboratory of Drug Research
Language: English

Topic: Galectins and Cancer Biology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: galectin-3, galectin-3 inhibitors, beta-galactoside-binding lectin, inflammation, fibrosis, heart failure biomarkers, heart disease, lung disease, renal dysfunction, liver fibrosis, structure-activity relationship, pharmacophore model, antibody-drug conjugates, carbohydrate polymers, polysaccharides, cancer therapy, drug discovery
SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Guangdong Science and Technology Department, Zhongshan Science and Technology Bureau
Awards: G230401369, G5044284783, G7880762443
OpenAlex ID: W7212379990
FWCI:
Cites: 234
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security